Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma

Mai, Elias K.; Hielscher, Thomas; Bertsch, Uta; Schlenzka, Jana; Salwender, Hans J.; Munder, Markus; Gerecke, Christian; Duehrsen, Ulrich; Brossart, Peter; Neben, Kai; Hillengass, Jens; Raab, Marc S.; Merz, Maximilian; Baertsch, Marc-Andrea; Jauch, Anna; Hose, Dirk; Martin, Hans; Lindemann, Hans-Walter; Blau, Igor W.; Scheid, Christof; Weisel, Katja C.; Goldschmidt, Hartmut

dc.contributor.author	Weisel, Katja
dc.date.accessioned	2020-06-15T11:00:55Z
dc.date.available	2020-06-15T11:00:55Z
dc.date.issued	2019
dc.identifier.issn	1476-5551
dc.identifier.uri	http://hdl.handle.net/10900/101460
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/s41375-018-0195-9	de_DE
dc.subject.ddc	610	de_DE
dc.title	Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190926111821_03323
utue.publikation.seiten	258-261	de_DE
utue.personen.roh	Mai, Elias K.
utue.personen.roh	Hielscher, Thomas
utue.personen.roh	Bertsch, Uta
utue.personen.roh	Schlenzka, Jana
utue.personen.roh	Salwender, Hans J.
utue.personen.roh	Munder, Markus
utue.personen.roh	Gerecke, Christian
utue.personen.roh	Duehrsen, Ulrich
utue.personen.roh	Brossart, Peter
utue.personen.roh	Neben, Kai
utue.personen.roh	Hillengass, Jens
utue.personen.roh	Raab, Marc S.
utue.personen.roh	Merz, Maximilian
utue.personen.roh	Baertsch, Marc-Andrea
utue.personen.roh	Jauch, Anna
utue.personen.roh	Hose, Dirk
utue.personen.roh	Martin, Hans
utue.personen.roh	Lindemann, Hans-Walter
utue.personen.roh	Blau, Igor W.
utue.personen.roh	Scheid, Christof
utue.personen.roh	Weisel, Katja C.
utue.personen.roh	Goldschmidt, Hartmut
dcterms.isPartOf.ZSTitelID	Leukemia	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	33	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE